Non-invasive imaging for studying anti-angiogenic therapy effects.
about
Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?Micro-RNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences?Quantitative Micro-Computed Tomography Imaging of Vascular Dysfunction in Progressive Kidney DiseasesImproving In Vivo High-Resolution CT Imaging of the Tumour Vasculature in Xenograft Mouse Models through Reduction of Motion and Bone-Streak ArtefactsThe "Fingerprint" of Cancer Extends Beyond Solid Tumor Boundaries: Assessment With a Novel Ultrasound Imaging Approach.Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.The Theranostic Path to Personalized NanomedicineCCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.Correlative Imaging of the Murine Hind Limb Vasculature and Muscle Tissue by MicroCT and Light Microscopy.Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imagingIn situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.Evaluation of new morphometric parameters of neoangiogenesis in human colorectal cancer using confocal laser endomicroscopy (CLE) and targeted panendothelial markers.Evaluation of Antitumor Activity of Long-Circulating and pH-Sensitive Liposomes Containing Ursolic Acid in Animal Models of Breast Tumor and Gliosarcoma.Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2.Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial BioparametersMicro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization.Applications of nanoparticles for diagnosis and therapy of cancer.Photoacoustic Tomography Detects Early Vessel Regression and Normalization During Ovarian Tumor Response to the Antiangiogenic Therapy Trebananib.Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma.Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints.Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical ImagingProbe-based confocal laser endomicroscopy for in vivo evaluation of the tumor vasculature in gastric and rectal carcinomas.PBCA-based polymeric microbubbles for molecular imaging and drug deliveryCT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours.
P2860
Q26752752-E9F4269F-A69C-4248-8530-609A3DD40E1EQ27005811-96B23A13-4EFC-4F36-A039-EA8FB461C7F9Q27342525-597C1744-8131-4EF3-8CB0-B589945BD07BQ28645717-08327037-D6DA-4BD1-B5FD-A99AE2BF5B79Q30357641-5CD1DC03-C89D-479D-A5E2-16FF497B92EEQ30365404-C18140FF-551E-4878-89EB-7AA9D46D2C8DQ30437998-AFD3A44D-95E4-4E16-8364-C5C63C6484C6Q30596736-60C5D1DD-CAE8-401F-B9B7-810DC184C6ABQ30837730-8A12DCE9-08BA-47F4-B3FC-71FC92092FC2Q33651804-6C195FAD-A7BD-452A-8EF4-73F967DF1EB6Q33687901-E16084C7-E2E8-49AE-AF0A-20DEF7EA52F7Q33823191-CA1431D8-B99E-4899-9A3D-F88D0DB81EC8Q35068706-6FF7551E-D288-4C56-8038-6F57EA1BB8BFQ35116363-08DE220B-C3F4-46BB-A349-016DA7F817DCQ36004070-F9E283A0-5FC3-4C1A-AC99-FFF5C945AA36Q36033915-772B83AD-F536-4BD9-B9B1-E79E8BCF6AB3Q37291272-54640AA7-393A-42BE-A1F8-F91BA29ADFFAQ37575598-1E29EF6F-1428-49C6-B6C4-E6F078C8AF93Q38477152-ABC02C31-6072-431E-B50C-815DB7944615Q38840159-ADF56898-CF05-41D9-A818-6F2064A014AEQ38969661-E49B21C7-7179-416F-AA71-9A24C5C0459CQ39084926-F2AD8D58-6FED-4377-BF5F-18284FEE06BAQ39135714-B031BC02-E970-456F-A981-D8919222404EQ40065892-E9AD0BE9-EE6F-4930-B138-1BA0D007FF79Q41131686-95A0049F-368A-4AA8-B412-FCFC0A62651CQ51709008-AE528FD3-C102-4E77-8FF4-9B2679355C43
P2860
Non-invasive imaging for studying anti-angiogenic therapy effects.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Non-invasive imaging for studying anti-angiogenic therapy effects.
@ast
Non-invasive imaging for studying anti-angiogenic therapy effects.
@en
type
label
Non-invasive imaging for studying anti-angiogenic therapy effects.
@ast
Non-invasive imaging for studying anti-angiogenic therapy effects.
@en
prefLabel
Non-invasive imaging for studying anti-angiogenic therapy effects.
@ast
Non-invasive imaging for studying anti-angiogenic therapy effects.
@en
P2860
P356
P1476
Non-invasive imaging for studying anti-angiogenic therapy effects
@en
P2093
Fabian Kiessling
Josef Ehling
P2860
P304
P356
10.1160/TH12-10-0721
P50
P577
2013-02-14T00:00:00Z